OpenVSafe by OpenVAERS
Search V-safe

E2V-15585-96422

2 vaccinations 6 coded responses 9 check-ins 6 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
335 / FL
Registered
2021-03-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-26
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-27
    Registered in v-safe
  4. 2021-03-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Extremely swollen lymph node above my collarbone, about the size of a large grape
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Joint range of motion decreased, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lymph nodes above collarbone are severely swollen, to the point of limiting range of motion.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lymph nodes above collarbone still very swollen. Slightly less than yesterday but still uncomfortable.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Lymph nodes above collarbone still greatly enlarged.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Headache
    Free text: Lymph node above collarbone still enlarged.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-04
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph nodes above collarbone
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-09
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-16
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-06-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech
22021-03-26Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-27

Systemic reaction (other): Extremely swollen lymph node above my collarbone, about the size of a large grape

2021-03-28

Systemic reaction (other): Lymph nodes above collarbone are severely swollen, to the point of limiting range of motion.

2021-03-29

Systemic reaction (other): Lymph nodes above collarbone still very swollen. Slightly less than yesterday but still uncomfortable.

2021-03-30

Systemic reaction (other): Lymph nodes above collarbone still greatly enlarged.

2021-04-01

Systemic reaction (other): Lymph node above collarbone still enlarged.

Release 6 — day 7, dose 2

2021-04-04

Systemic reaction (other): Swollen lymph nodes above collarbone

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROJoint range of motion decreased ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release